1 2 3 4 5 6 7 8 9 10 11 12 13

KUMAR11

Ganrot PO. Metabolism and possible health effects of aluminium. Environ


Hlth Perspect1986; 65:363-441


Glowinski J, Iversen LL.Regional studies of catecholamines in the


rat brain. I. The disposition of[3H] dopamine and [3H] DOPA in various


regions of rat brain. J Neurochem 1966; 13:655-699

Gulya
K,
Watson
M,
Yamamura

HI.

Examination

of

cholinergic

and

neuropeptide


type. In:

receptor

alteration

in

senile

dementia

of

Alzheimer's

Advances in Behavioral Biology, Vol 29: Alzheimer's and

Parkinsons Diseases: Strategies for Research and Development, Fisher


A., Hanin I., Lachman., eds., New York, Plenum, pp 109-116


Gulya K, Rakonczay Z, Kasa P.Cholinotoxic effects of aluminium in


rat brain.J Neurochem1990; 54:1020-1026


Lowry OH, Rosebrough NJ, Fare AL, Randall RJ. Protein measurement


with the folin phenol reagent. J Biol Chem 1951; 193:265-275


Marquis JK, Black EE.Aluminium activation and inactivation of bovine

caudate

acetylcholinesterase.

Bull

Environ

Contam

Toxicol

1984;

32:704-710

Marquis
JK,
Lerrick

AJ.


of

Noncompetitive

inhibition

by

aluminium,

scandium

and

yttrium

acetylcholinesterase

from

Electrophorus

electricus. Biochem

Pharmac 1982; 31:1437-1440

Mazzanti L, Pastuszko A, Lenaz G. Effects of ketamine anesthesia on

rat

brain

membranes:

Fluidity

changes

and

kinetics

of

acetylcholinesterase. Biochem Biophys Acta1986; 861:105-110

McGeer
PL,
McGeer
EG,
Suzuki
J,
Dolman
CE,
Nagai
  1. Aging,

Alzheimer's disease and the cholinergic system of the basal forebrain.


Neurol1984; 34:741-745